Dual Therapy With Dolutegravir And Lamivudine | Pedro Cahn, Md, Phd

Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Original)

Academic Medical Education

Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Portuguese)

Academic Medical Education

Dual Therapy Using INSTIs - Pedro Cahn, MD, PhD

Academic Medical Education

Efficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy Vavro

Academic Medical Education

Tolerability of Dolutegravir and the other INSTI’s

MWAETC: Project ECHO

Clinical Case -Reduced Drug Regimen | Pedro Cahn, MD, PhD

Academic Medical Education

Dovato (dolutegravir and lamivudine)- HIV

Pharmacy Talk USA

ART Simplification Strategy - Pedro Cahn, MD, PhD

Academic Medical Education

Induction-Maintenance ARV Therapy: Why, Who, When and How? | Pedro Cahn, MD, PhD

Academic Medical Education

DOVATO [Dolutegravir and Lamivudine ]

DOVATO® (dolutegravir/lamivudine) Mechanism of Action for HIV

Simplified regimens: pros and cons | Pedro Cahn, MD, PhD

Academic Medical Education

Mini-Lecture Series: Dolutegravir-Lamivudine

National HIV Curriculum

Clinical Case Discussion 1 | Pedro Cahn, MD, PhD

Academic Medical Education

The Transition to Dolutegravir-Based ART Regimes: Opportunities and Challenges

ICAP at Columbia University

Dual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD

Academic Medical Education

08. Switching ART to safer strategies based on INIs - Pedro Cahn | Aging in HIV BCN 2018

The Importance of Drug-Drug Interactions in ART | David Back, PhD (Original)

Academic Medical Education

Two-Drug Approaches for HIV Treatment